Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Centene (NYSE:CNC) Stock Price

Centene (NYSE:CNC) had its target price upped by Deutsche Bank Aktiengesellschaft from $32.00 to $39.00 in a research report report published on Tuesday, MarketBeat.com reports. They currently have a hold rating on the stock.

A number of other analysts also recently commented on CNC. Zacks Research upgraded shares of Centene from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 29th. JPMorgan Chase & Co. boosted their target price on Centene from $38.00 to $45.00 and gave the stock a “neutral” rating in a report on Thursday, January 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $59.00 price target on shares of Centene in a research note on Tuesday, January 6th. Barclays set a $44.00 price objective on Centene and gave the stock an “equal weight” rating in a research note on Tuesday, November 4th. Finally, Wall Street Zen raised Centene from a “hold” rating to a “buy” rating in a research note on Saturday. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $41.25.

Centene Stock Performance

Shares of NYSE CNC opened at $39.61 on Tuesday. Centene has a 12-month low of $25.08 and a 12-month high of $66.03. The company has a market cap of $19.47 billion, a PE ratio of -2.91, a P/E/G ratio of 0.84 and a beta of 0.48. The stock has a 50 day simple moving average of $42.04 and a 200-day simple moving average of $36.15. The company has a current ratio of 1.10, a quick ratio of 1.08 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The company had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. During the same quarter in the previous year, the firm posted $0.80 EPS. The firm’s quarterly revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, equities research analysts forecast that Centene will post 6.86 EPS for the current year.

Institutional Trading of Centene

A number of hedge funds have recently bought and sold shares of CNC. WPG Advisers LLC raised its holdings in shares of Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after acquiring an additional 282 shares during the period. Prime Capital Investment Advisors LLC grew its position in Centene by 5.7% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 5,975 shares of the company’s stock worth $246,000 after purchasing an additional 324 shares in the last quarter. Burney Co. raised its stake in Centene by 3.8% during the 4th quarter. Burney Co. now owns 9,053 shares of the company’s stock valued at $373,000 after purchasing an additional 331 shares during the period. Versant Capital Management Inc lifted its holdings in shares of Centene by 11.6% in the third quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after purchasing an additional 355 shares in the last quarter. Finally, Sapient Capital LLC boosted its position in shares of Centene by 4.0% in the fourth quarter. Sapient Capital LLC now owns 9,442 shares of the company’s stock worth $389,000 after buying an additional 359 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.